Skip to content

Clinical trials

Phase 2 Fallopian Tube Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20141
20181
20193
20212
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting4
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics2
AbbVie1
Bristol-Myers Squibb1
Eli Lilly and Company1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Fore Biotherapeutics1
Glycotope GmbH1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Mario Negri Institute for Pharmacological Research1
North Eastern German Society of Gynaecological Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms14
Ovarian Neoplasms13
Carcinoma, Ovarian Epithelial2
Neoplasms2
Adenocarcinoma, Clear Cell1
Anemia1
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma, Hepatocellular1
Cholangiocarcinoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.